28 June 2022 | 16:50

Weekly update on the coronavirus SARS-CoV-2:  28 June 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance. For more background information see the news: SARS-CoV-2 infections continue to rise.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, the percentage of people who reported possible symptoms of COVID-19 stabilised at about 3.5%. The number of people who were tested for COVID-19 and the number of newly reported positive COVID-19 tests increased (+29%) last week compared to the week before that. This increase was observed in all age groups and in all security regions. On 13 June 2022, the reproduction number based on reported positive tests was above 1. The number of new hospital admissions of patients with SARS-CoV-2 increased 7%, while the number of new patients with SARS-CoV-2 in the ICU rose 10%, compared to the week before.

Sewage surveillance

In sewage surveillance, an increase of 49.2% was observed in the national average number of virus particles in week 24 compared to week 23. Once again, viral loads were highest in the metropolitan area, particularly in and around Amsterdam. In the first half of week 25, the average number of virus particles continued to increase, rising by 30.3%; at that time, those levels were particularly high in and around The Hague. The Omicron sub-variant BA.2 is still present in sewage, but the BA.5 Omicron sub-variant was observed most frequently in week 24. The BA.4 sub-variant was found to a lesser extent, and the BA.2.12.1 sub-variant continued to decrease significantly.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variant BA.2.12.1), BA.3, BA.4 and BA.5. Many countries have recently seen an increase in sub-variants BA.4 and BA.5. BA.2.12.1 is also increasing in some countries. The data from pathogen surveillance shows that BA.5 became dominant in the Netherlands in June 2022. Saltro’s variant PCR data shows the same trend. 

According to the WHO, these new variants do not appear to cause more serious illness than the BA.2 variant that was recently most prevalent in the Netherlands. However, there are indications that antibodies may be less effective against these variants. 
 

 GGD reports to RIVM between 21 June 2022 10:01 and 28June 2022 10:00 as published 28 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

² GGD reports to RIVM between 14 June 2022 10:01 and 21 June 2022 10:00 as published 21 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

³ As published 28 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.

⁴Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

⁵ Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

⁶ As published 28 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.

⁷ For more information about the reproduction number, click here.

⁸ The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.

9 Based on data available at RIVM on Monday afternoon, 27 June 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.

¹⁰ In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.

¹¹ Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.

¹² Number of people connected to the number of sampling locations on which the average is based. 

28 June 2022 | 16:30

Vaccination figures: 20 June – 26 June 2022

Up to and including Sunday 26 June 2022, more than 2.2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 45.7%. For the past two weeks, the weekly number of repeat vaccinations has been increasing. 59% more repeat vaccinations were administered last week compared to the week of 6 June. The strongest increase was seen in the age group of people aged 60 to 70 years. 

Read more in the weekly update on COVID-19 vaccination figures. 

 21 June 2022 | 16:30

Weekly update on the coronavirus SARS-CoV-2:  21 June 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance. 

For more information read the news: Upward trend in infections continues

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, the percentage of people who reported possible symptoms of COVID-19 continued rising to above 3%. The number of people who were tested for COVID-19 and the number of newly reported positive COVID-19 tests increased significantly (+70%) last week compared to the week before that. This increase was observed in all age groups and in all security regions. On 6 June 2022, the reproduction number based on reported positive tests was above 1. The number of new hospital admissions of patients with SARS-CoV-2 stabilised, but the number of new patients with SARS-CoV-2 in the ICU rose by 37%, compared to the week before.

Sewage surveillance

In sewage surveillance, an increase of 37.6% was observed in the national average number of virus particles in week 23 compared to week 22. As in last week’s update, the average number of virus particles was particularly high in and around Amsterdam and The Hague. In the first half of week 24, the average number of virus particles continued to increase, rising by 34.1%. The Omicron sub-variant BA.2 is still very present in sewage, but a significant increase in the number of sewage samples containing mutations specifically associated with BA.5 was observed again in week 23. The BA.4 mutations were found to a lesser extent, and there was a significant decrease in the mutations specific to BA.2.12.1.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variant BA.2.12.1), BA.3, BA.4 and BA.5. Many countries have recently seen an increase in sub-variants BA.4 and BA.5. BA.2.12.1 is also increasing in some countries. Based on the latest pathogen surveillance data, trend forecasts for Omicron sub-variants BA.4, BA.5 and BA.2.12.1 suggest that BA.5 will become dominant. Saltro’s variant PCR data shows a comparable trend, indicating that the combined percentage of BA.4/BA.5 became dominant in early June. 

 ¹ GGD reports to RIVM between 14 June 2022 10:01 and 21 June 2022 10:00 as published 21 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

² GGD reports to RIVM between 7 June 2022 10:01 and 14 June 2022 10:00 as published 14 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

³ As published 21 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.

⁴Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

⁵ Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

⁶ As published 21 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.

⁷ For more information about the reproduction number, click here.

⁸ The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.

9 Based on data available at RIVM on Monday afternoon, 20 June 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.

¹⁰ In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.

¹¹ Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.

¹² Number of people connected to the number of sampling locations on which the average is based.

21 June 2022 | 16:00

Vaccination figures: 13 June – 19 June 2022

Up to and including Sunday 19 June 2022, more than 2.1 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 44.2%.

Read more in the weekly update on COVID-19 vaccination figures. 

14 June 2022 | 19:30

Weekly update on the coronavirus SARS-CoV-2:  14 June 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

More information : read the news Many more infections, limited increase in hospital admissions

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week,the percentage of people who reported possible symptoms of COVID-19 continued to increase, rising to over 3%. The number of people who were tested for COVID-19 and the number of newly reported positive COVID-19 tests increased significantly (+64%) last week compared to the week before that. This increase was observed in all age groups and security regions. On 30 May 2022, the reproduction number based on reported positive tests was above 1. The number of new hospital admissions of patients with SARS-CoV-2 increased by 12% and the number of new patients with SARS-CoV-2 in the ICU remained the same, compared to the week before.

Sewage surveillance

In sewage surveillance, an increase of +62.4% was observed in the national average number of virus particles in week 22 compared to week 21. The average number of virus particles was particularly high in and around Amsterdam and The Hague, In the first half of week 22, the average number of virus particles continued to increase, rising by +37,3%. The Omicron sub-variant BA.2 is still very present in sewage, but from week 20 on, there was a significant increase in the number of sewage samples containing mutations specifically associated with BA.4, BA.5 and BA.2.12.1. In weeks 21 and 22, the upward trend seemed to continue in particular for the specific mutations associated with sub-variant BA.5.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variant BA.2.12.1), BA.3, BA.4 and BA.5. However, it is currently very unclear which Omicron sub-variant is spreading fastest and will become dominant. Based on the latest pathogen surveillance data and the variant PCR data, there has been an increase in BA.4 and BA.4; the variant PCR provides slightly more up-to-date data. Based on this variant PCR data, these two sub-variants represented over half of total numbers by the end of last week. In addition to BA.4 and BA.5, pathogen surveillance also shows an increase in a BA.2 sub-variant, BA.2.12.1.

¹ GGD reports to RIVM between 7 June 2022 10:01 and 14 June 2022 10:00 as published 14 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
² GGD reports to RIVM between 31 May 2022 10:01 and 7 June 2022 10:00 as published 7 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 14 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.
⁴Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
⁵ Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.
⁶ As published 14 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.
⁷ For more information about the reproduction number, click here.
⁸ The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.
9 Based on data available at RIVM on Monday afternoon, 13 June 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.
¹⁰ In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.
¹¹ Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.
¹² Number of people connected to the number of sampling locations on which the average is based.

14 June 2022 | 16:00

Vaccination figures: 6 June – 12 June 2022

Up to and including Sunday 12 June 2022, more than 2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 43.1%.

See:  Archive COVID-19 vaccination figures 2022

7 June 2022 | 15:40 PM

Weekly update on the coronavirus SARS-CoV-2:  7 June 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, the percentage of people who reported possible symptoms of COVID-19 rose from about 2% to about 3%. The number of people who were tested for COVID-19 and the number of newly reported positive COVID-19 tests increased (+33%) last week compared to the week before that. This increase was observed in all age groups, except among children aged 0-12 years, and the largest increase was among people aged 13-29 years. On 19 May 2022, the reproduction number based on reported positive tests was around 1. The number of new hospital admissions of patients with SARS-CoV-2 decreased by 23% and the number of new patients with SARS-CoV-2 in the ICU stabilised, compared to the week before.

Sewage surveillance

In sewage surveillance, a slight decrease of -8.7% was observed in the national average number of virus particles in week 21 compared to week 20. In the first two days of week 22, the average number of virus particles increased slightly again, rising by +7.8%. Sewage surveillance figures seem to have plateaued for the time being. However, the average number of virus particles in and around the major cities (Amsterdam, Rotterdam, The Hague) is high compared to the rest of the Netherlands. The Omicron sub-variant BA.2 is still very present in sewage, but in week 20, there was a significant increase in the number of sewage samples containing mutations specifically associated with BA.4, BA.5 and BA.2.12.1. In week 21, the upward trend seemed to continue in particular for the specific mutations associated with sub-variants BA.5 and BA.2.12.1.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2, BA.3, BA.4 and BA.5. The BA.2 sub-variant is currently dominant in the Netherlands. The percentage of sub-variants BA.4, BA.5 and BA.2.12.1, a sub-variant of BA.2, is increasing in pathogen surveillance. However, it is currently very unclear which Omicron sub-variant is spreading fastest and will become dominant.   BA.4 and BA.5 differ in some respects, but have the same changes in the spike protein, and are therefore likely to have very similar properties. BA.2.12.1 has another change in the spike protein. There is currently no reason to believe that any of these sub-variants would cause a more severe course of disease. 

¹ GGD reports to RIVM between 31 May 2022 10:01 and 7 June 2022 10:00 as published 7 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
² GGD reports to RIVM between 24 May 2022 10:01 and 31 May 2022 10:00 as published 31 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 7 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.
⁴Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
⁵ Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.
⁶ As published 7 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.
⁷ For more information about the reproduction number, click here.
⁸ The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.
9 Based on data available at RIVM on Monday afternoon, 6 June 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.
¹⁰ In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.
¹¹ Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.
¹² Number of people connected to the number of sampling locations on which the average is based.

31 May 2022 | 16:10 PM

Weekly update on the coronavirus SARS-CoV-2:  31 May 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital occupancy, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, , there was a stabilisation in the percentage of people who reported possible symptoms of COVID-19. . The number of newly reported positive COVID-19 tests recorded by the Municipal Public Health Services (GGDs) decreased slightly (-5%) last week compared to the week before that. The reproduction number is below 1. The number of new hospital admissions of patients with SARS-CoV-2 decreased by 31% and the number of new patients with SARS-CoV-2 in the ICU decreased by 22%, compared to the week before.

Sewage surveillance

In sewage surveillance, a very slight increase of +3.5% was observed in the national average number of virus particles in week 20 compared to week 19. In the first half of week 21, the average number of virus particles decreased slightly again, dropping by -3.6%; sewage surveillance figures seem to have plateaued. In weeks 18 and 19, an increasing number of sewage samples were found to contain mutations associated with the Omicron sub-variants BA.4, BA.5 and BA.2.12.1. In week 20, there was a significant increase in the number of sewage samples containing specific mutations associated with BA.4, BA.5 and BA.2.12.1. At five sampling locations, BA.5 was the most common variant in the sewage sample.

Virus variants from pathogen surveillance

A continued increase in BA.4 and BA.5 has been observed in recent weeks in the context of pathogen surveillance.  

Based on pathogen surveillance, trend forecasts for these sub-variants suggest that they may become dominant in June 2022. The increase in BA.4 and BA.5 is also being monitored in cooperation with Saltro by means of variant PCR. Variant PCR data can be accessed sooner and offers an indication for whether the BA.4/5 sub-variants are present, although this method does not detect their presence with certainty; sequencing is performed to confirm which variant is involved.  Trend forecasts for BA.4 and BA.5 based on this more recent variant PCR data suggest that these sub-variants may become dominant as soon as early June 2022. However, the margins of uncertainty are still significant.  

Some countries have observed an increase in a BA.2 sub-variant, designated BA.2.12.1. This sub-variant is also increasing in pathogen surveillance, but has not been included in the current forecast. This sub-variant cannot be distinguished from BA.2 based on Saltro’s variant PCR data. Which Omicron sub-variant is spreading fastest is currently unclear. 

¹ GGD reports to RIVM between 24 May 2022 10:01 and 31 May 2022 10:00 as published 31 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
² GGD reports to RIVM between 17 May 2022 10:01 and 24 May 2022 10:00 as published 24 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 31 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.
⁴Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
⁵ Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.
⁶ As published 31 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.
⁷ For more information about the reproduction number, click here.
⁸ The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.
9 Based on data available at RIVM on Monday afternoon, 30 May 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.
¹⁰ In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.
¹¹ Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.
¹² Number of people connected to the number of sampling locations on which the average is based.

31 May 2022 | 16:00

Vaccination figures: 23 to 29 May 2022

Up to and including Sunday 29 May, more than 2 million repeat vaccinations had been administered in the Netherlands. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 41.8%.

See:  Archive COVID-19 vaccination figures 2022

24 May 2022 | 15:30 PM

Weekly update on the coronavirus SARS-CoV-2:  24 May 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital occupancy, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, , there was a stabilisation in the percentage of people who reported possible symptoms of COVID-19. The number of newly reported positive COVID-19 tests decreased (-11%) last week compared to the week before that. The reproduction number is below 1. The number of new hospital admissions of patients with SARS-CoV-2 decreased by 18% and the number of new patients with SARS-CoV-2 in the ICU stabilised, compared to the week before.

Sewage surveillance

In sewage surveillance, a decrease of 15.7% was observed in the national average viral load in week 19 compared to week 18. In the first half of week 20, the average viral load continued to decrease slightly, dropping 6.3%. Omicron variant BA.2 had been the main variant found in the sewage samples in the past few weeks. In weeks 18 and 19, an increasing number of samples were found to contain shared BA.4/BA.5 mutations, as well as more specific mutations associated with BA.4 and BA.5. BA.2.12.1 was also detected in more samples.

Virus variants from pathogen surveillance

An increase in BA.4 and BA.5 has been observed in recent weeks in the context of pathogen surveillance. Trend forecasts for these sub-variants suggests that they may become dominant in July 2022. However, the margins of uncertainty are still very significant. Since BA.4 and BA.5 are currently only showing up in low numbers in pathogen surveillance, it is not yet possible to predict which of these two sub-variants will become dominant. For that reason, the current forecast displays these two together as BA.4/BA.5.  

Some countries have observed an increase in a BA.2 sub-variant, designated BA.2.12.1. This sub-variant has also been detected in pathogen surveillance, but has not been included in the current forecast. Which sub-variant is spreading fastest is currently unclear.

¹ GGD reports to RIVM between 17 May 2022 10:01 and 24 May 2022 10:00 as published 24 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
² GGD reports to RIVM between 10 May 2022 10:01 and 17 May 2022 10:00 as published 17 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 24 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.
⁴Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
⁵ Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.
⁶ As published 24 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.
⁷ For more information about the reproduction number, click here.
⁸ The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.
9 Based on data available at RIVM on Monday afternoon, 23 May 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.
¹⁰ In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.
¹¹ Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.
¹² Number of people connected to the number of sampling locations on which the average is based.

17 May 2022 | 16:15

Vaccination figures: 9 to 15 May 2022

Up to and including Sunday 15 May, more than 1.9 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 39.9%.

Read more in the weekly update on COVID-19 vaccination figures.

17 May 2022 | 16:15 PM

Weekly update on the coronavirus SARS-CoV-2:  17 May 2022

As of today (17 May 2022), we are expanding the information on this page about the coronavirus SARS-CoV-2. In addition to figures on positive tests and hospital occupancy, we will also be adding information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, there was a drop in the percentage of people who reported possible symptoms of COVID-19. The number of newly reported positive COVID-19 tests decreased (16%) last week compared to the week before that. The reproduction number is also below 1. The number of new hospital admissions of patients with SARS-CoV-2 decreased by 31% and the number of new patients with SARS-CoV-2 in the ICU also decreased by 26%, compared to the week before.

Sewage surveillance

In week 18, the national average for virus particles in sewage increased slightly, rising by 7.1% compared to week 17. In the first half of week 19, the average number of virus particles decreased by 21.0%.

Omicron variant BA.2 was the main variant found in the sewage samples. Looking at the sub-variants of BA.2, samples primarily contained the sub-variant BA.2.9, to a lesser extent BA.2.3 and in a few cases BA.2.12. The number of sewage samples with BA.4/BA.5 mutations increased this week compared to last week.

Virus variants from pathogen surveillance

In recent weeks, Omicron variant BA.2 has been the most prevalent. This variant was found in 98% of all samples sequenced in weeks 16 and 17. Omicron BA.4 was detected 3 times: in weeks 14, 15 and 16. Omicron BA.5 was detected once in week 16 and twice in week 17.

¹ Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission. Current figures on hospital admissions of patients with SARS-CoV-2 categorised by admission reason can be viewed on the RIVM graphs page, or in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
¹ GGD reports to RIVM between 10 May 2022 10:01 and 17 May 2022 10:00 as published 17 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
² GGD reports to RIVM between 3 May 2022 10:01 and 10 May 2022 10:00 as published 10 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 17 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.
⁴Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
⁵ Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.
⁶ As published 17 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.
⁷ For more information about the reproduction number, click here.
⁸ The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.
9 Based on data available at RIVM on Monday afternoon, 16 May 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.
¹⁰ In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.
¹¹ Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.
¹² Number of people connected to the number of sampling locations on which the average is based. 

11 May 2022 | 16:00

Repeat vaccination restores protection against hospital admission to level shortly after booster

In the period from 1 February 2022 to 3 May 2022, vaccine effectiveness of the repeat vaccination against COVID-19 in preventing hospital admission was 88%. In the same period, vaccine effectiveness in preventing hospital admission was 78% among people aged 70 years and older who had received the booster jab but not the repeat vaccination, and 37% among people who had only received the basic series of COVID-19 vaccinations.

Read more: Repeat vaccination restores protection against hospital admission to level shortly after booster

11 May 2022 | 8:30

Vaccination figures: 2 to 8 May 2022

Up to and including Sunday 8 May, more than 1.8 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 38.9%.

Read more in the weekly update on COVID-19 vaccination figures.

10 May 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2:  3 May to 10 May 2022

ast week, the number of new hospital admissions of patients¹ with SARS-CoV-2 decreased by 28% and the number of new patients with SARS-CoV-2 in the ICU also decreased by 32%, compared to the week before. The number of newly reported COVID-19 tests decreased slightly (-6%) compared to the week before. 

The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

03 May 2022 | 16:00

Vaccination figures: 25 April to 1 May 2022

Up to and including Sunday 1 May, more than 1.8 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 37.7%.

Read more in the weekly update on COVID-19 vaccination figures.

3 May 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2: 26 april to 3 May 2022

Last week, the number of new hospital admissions of patients¹ with SARS-CoV-2 decreased by 40% and the number of new patients with SARS-CoV-2 in the ICU also decreased by 40%, compared to the week before. The number of newly reported positive COVID-19 tests was also lower (-34%) last week compared to the week before that.

The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

26 April 2022 | 16:15

Protection from repeat vaccination remains effective against severe COVID-19

In the period from 1 February 2022 to 19 April 2022, vaccine effectiveness of the basic series of COVID-19 vaccinations in preventing hospital admission was 30%. After the booster jab, that percentage was 79%. 

Read the news: Protection from repeat vaccination remains effective against severe COVID-19

26 April 2022 | 16:00

Vaccination figures 18-24 April 2022

Up to and including Sunday 24 April, more than 1.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 35.8%.

Read more in the weekly update on COVID-19 vaccination figures.

26 April 2022 | 16:00 PM

Weekly update on the coronavirus SARS-CoV-2: 19 April to 26 april 2022

Last week, the number of new hospital admissions of patients¹ with SARS-CoV-2 decreased by 35% and the number of new patients with SARS-CoV-2 in the ICU decreased by 29%, compared to the week before. The number of newly reported positive COVID-19 tests was also lower (-35%) last week compared to the week before that.

The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

From Saturday, 9 April 2022, no data will be published on weekends and public holidays* (days off). This is in line with the current situation regarding the coronavirus SARS-CoV-2. RIVM continues to monitor the development of the virus closely.

*Public holidays on which data will not be reported: New Year’s Day, Easter Sunday and Easter Monday, King’s Day, Liberation Day, Ascension Day, Whit Sunday and Whit Monday, Christmas Day and Boxing Day (in 2022: Saturday 1 January, Sunday 17 and Monday 18 April, Wednesday 27 April, Thursday 5 May, Thursday 26 May, Sunday 5 June and Monday 6 June, Sunday 25 and Monday 26 December).
 

19 April 2022 | 16:00

Vaccination figures 11-17 April 2022

Up to and including Sunday 17 April, more than 1.5 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has reached 32.7%.

Read more in the weekly update on COVID-19 vaccination figures.

19 April 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2: 12 April to 19 april 2022

Last week, the number of new hospital admissions of patients with SARS-CoV-2¹ decreased by 53%* and the number of new patients with SARS-CoV-2 in the ICU decreased by 31%*, compared to the week before. The number of newly reported positive COVID-19 tests was also lower (-63%) last week compared to the week before that. Since last Monday, 11 April 2022, positive self-tests no longer need to be confirmed by the Municipal Public Health Services (GGDs). As a result, the number of people who get a GGD test to confirm a positive self-test will decrease. This means that the number of positive COVID-19 tests cannot be fully compared to previous weeks.

The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

From Saturday, 9 April 2022, no data will be published on weekends and public holidays* (days off). This is in line with the current situation regarding the coronavirus SARS-CoV-2. RIVM continues to monitor the development of the virus closely.

*Public holidays on which data will not be reported: New Year’s Day, Easter Sunday and Easter Monday, King’s Day, Liberation Day, Ascension Day, Whit Sunday and Whit Monday, Christmas Day and Boxing Day (in 2022: Saturday 1 January, Sunday 17 and Monday 18 April, Wednesday 27 April, Thursday 5 May, Thursday 26 May, Sunday 5 June and Monday 6 June, Sunday 25 and Monday 26 December).
 

12 April 2022 | 16:00

Repeat vaccination effective in preventing severe COVID-19

In the period from 1 February 2022 to 5 April 2022, vaccine effectiveness of the basic series of COVID-19 vaccinations in preventing hospital admission was 35%. After the booster vaccination, that percentage was 81%. Vaccine effectiveness against ICU admission was 45% after the basic series, compared to 90% after booster vaccination. 

Read the news: Repeat vaccination effective in preventing severe COVID-19

12 April 2022 | 16:00

Vaccination figures 4-10 April 2022

Up to and including Sunday 10 April, more than 1.3 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has reached 28.5%.

Read more in the weekly update on COVID-19 vaccination figures.

12 April 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2:   5 April to 12 april 2022

Last week, the number of new hospital admissions of patients with SARS-CoV-2 decreased by 29%* compared to the week before, and the number of new patients with SARS-CoV-2 in the ICU decreased by 20%*. The number of newly reported positive COVID-19 tests was also lower (-48%) last week compared to the week before that. 

The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

From Saturday, 9 April 2022, no data will be published on weekends and public holidays* (days off). This is in line with the current situation regarding the coronavirus SARS-CoV-2. RIVM continues to monitor the development of the virus closely.

*Public holidays on which data will not be reported: New Year’s Day, Easter Sunday and Easter Monday, King’s Day, Liberation Day, Ascension Day, Whit Sunday and Whit Monday, Christmas Day and Boxing Day (in 2022: Saturday 1 January, Sunday 17 and Monday 18 April, Wednesday 27 April, Thursday 5 May, Thursday 26 May, Sunday 5 June and Monday 6 June, Sunday 25 and Monday 26 December).
 

5 April 2022 | 16:00

Vaccination figures: 28 March to 3 April 2022

Up to and including Sunday 3 April, more than 1 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19. They can get the repeat vaccination 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. As of this week, this report also includes vaccination coverage and the graph by age for the repeat vaccination against COVID-19. Vaccination coverage for the repeat vaccination among people over 60 has reached 22.4%.

Read more in the weekly update on COVID-19 vaccination figures. 

5 April 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2:  29 March to 5 April 2022

Last week, the number of new hospital admissions of patients with SARS-CoV-2 in the Netherlands decreased by 32%* compared to the week before, and the number of new patients with SARS-CoV-2 in the ICU decreased by 35%*. The number of newly reported positive COVID-19 tests was also lower (-42%) last week compared to the week before that. The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

From Saturday, 9 April 2022, no data will be published on weekends and public holidays* (days off). This is in line with the current situation regarding the coronavirus SARS-CoV-2. RIVM continues to monitor the development of the virus closely.

*Public holidays on which data will not be reported: New Year’s Day, Easter Sunday and Easter Monday, King’s Day, Liberation Day, Ascension Day, Whit Sunday and Whit Monday, Christmas Day and Boxing Day (in 2022: Saturday 1 January, Sunday 17 and Monday 18 April, Wednesday 27 April, Thursday 5 May, Thursday 26 May, Sunday 5 June and Monday 6 June, Sunday 25 and Monday 26 December).
 

29 March 2022 | 16:40

Protection from COVID-19 booster remains high, but wanes slightly for everyone after 3 months

In the period from 1 February 2022 to 22 March 2022, when more than 99% of hospital admissions were caused by the Omicron variant, vaccine effectiveness of the basic series in preventing hospital admission was 45%. After the booster vaccination, that percentage was 82%. Vaccine effectiveness against ICU admission was 57% after the basic series, compared to 91% after booster vaccination. 

Read the news: Protection from COVID-19 booster remains high, but wanes slightly for everyone after 3 months

29 March 2022 | 16:15

Vaccination figures 21 to 27 March 2022

As of 4 March 2022, people aged 70 years and older, people living in nursing homes, and certain groups of people with impaired immunity can get a repeat vaccination against COVID-19. As of 26 March, this option is available to people aged 60 years and older. Up to and including Sunday 27 March, more than 725,000 repeat vaccinations had been administered.

Read more in the weekly update on COVID-19 vaccination figures.  

Weekly update on the coronavirus SARS-CoV-2:  22 to 29 March 2022

Last week, the number of new hospital admissions of patients with SARS-CoV-2 decreased by 19%* compared to the week before, and the number of new patients with SARS-CoV-2 in the ICU decreased by 9%*. The number of newly reported positive COVID-19 tests was also lower (-29%) last week compared to the week before that. The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

22 March 2022 | 16:30

Vaccination figures 14 to 20 March 2022

As of 4 March 2022, people aged 70 years and older, people living in nursing homes, and certain groups of people with impaired immunity can get a repeat vaccination against COVID-19. Up to and including Sunday 20 March, 429,000 repeat vaccinations had been administered. 

Numbers and vaccination coverage for the basic series

By Sunday 20 March 2022, it is estimated that nearly 25 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.

It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Read more in the weekly update on COVID-19 vaccination figures.  

22 March 2022 | 16:15 PM

Weekly update on the coronavirus SARS-CoV-2:  15 to 22 March 2022

Last week, there was a 7%* decrease in the number of new hospital admissions of patients with SARS-CoV-2. 15% more new COVID-19 patients were admitted to ICU compared to the week before*. The number of newly reported positive COVID-19 tests decreased by 27% last week compared to the week before that. Reported figures decreased in most age groups. The number of reported positive tests remained stable over the course of the week among people aged 70 years and older. However, even in that age group, the daily number of reported positive tests decreased during the week. The reproduction number is below 1.

See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays. Much of the data used to keep track of the SARS-CoV-2 figures is available to the public. These open data files are published every day at 15:15.

15 March 2022 | 16:57 PM

Vaccination figures 7 to 13 March 2022

Numbers and vaccination coverage for the basic series

By Sunday 13 March 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.

It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series

Read more in the weekly update on COVID-19 vaccination figures. 

15 March 2022 | 16:45 PM

Weekly update on the coronavirus SARS-CoV-2:  8 march to 15 March 2022

Last week, there was a 14% increase in the number of new hospital admissions of patients with SARS-CoV-2. 6% more new COVID-19 patients were admitted to ICU compared to the week before. In the Netherlands as a whole, the number of newly reported positive COVID-19 tests remained fairly stable (-2%) compared to the week before that. Reported figures increased in 15 of the 25 GGD regions. In the Carnival regions, which had reported the biggest increase two weeks ago, the number of newly reported positive tests decreased in the past week. The daily number of positive tests decreased or stabilised during the past week, at national and regional levels. In most age groups, there was a slower increase in reported positive tests compared to the previous week. The number of reported positive tests continued to rise sharply among older people: 66% in the age group of 60-69 years, 104% in the age group of 70-79 years, and 102% among people over 80. Although the number of reported positive tests had remained stable two weeks ago among children aged 0-12 years, the number of reported positive tests in that age group increased by 33% last week. This may be due to increased testing after the holidays. The reproduction number is above 1.

See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays. Much of the data used to keep track of the SARS-CoV-2 figures is available to the public. These open data files are published every day at 15:15.

8 March 2022 | 16:30 PM

Vaccination figures 28 February 2022 to 6 March 2022

Numbers and vaccination coverage for the basic series

By Sunday 6 March 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.

It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Read more in the weekly update on COVID-19 vaccination figures. 

8 March 2022 | 16:15 PM

Weekly update on the coronavirus SARS-CoV-2:  1 march to 8 March 2022

Significant increase in positive COVID-19 tests, rising highest in Carnival regions

After several weeks of decreasing figures in the Netherlands, the number of people who tested positive for SARS-CoV-2 in the past week rose to 439,775, from 245,898 a week before (+79%). 
This significant increase is a combined effect of the Carnival week and the relaxed measures. Reported figures increased in all regions. In various areas in the provinces of Noord-Brabant and Limburg, reported positive tests per 100,000 inhabitants reached the highest point yet. Reported positive tests also increased in other regions, but less sharply, and the weekly number of reported positive tests did not exceed the levels observed during the Omicron wave in January and February 2022. The number of people who were tested by the Municipal Public Health Services (GGDs) increased by +60%, rising to 594,865 tests. At the GGD test sites in Noord-Brabant and Limburg, the waiting time to get tested is currently longer than usual. 

Figure 1: Map of newly reported positive COVID-19 tests per 100,000 inhabitants in the past week (1 March to 8 March 2022) by municipality. 

The number of reported positive tests stabilised in the age group of 0-12 years. In all other age groups, the number of reported positive tests increased, doubling in the age groups of 18 to 24 years (+111%) and 25 to 29 years (+99%). Another striking trend this week is the major increase in the number of positive tests among people aged 60 years and over compared to a week before. During the Omicron wave in the first two months of this year, infections among this age group in particular remained stable and low compared to the large number of infections among younger age groups.

Last week, the number of new hospital admissions of patients with SARS-CoV-2 stabilised compared to the week before, and there were 16% fewer new patients in the ICU than in the week before that. On average, the impact of a rising infection rate on the number of hospital admissions becomes apparent about two weeks later. Because vulnerable people and older people have a higher risk of hospital admission after infection with the coronavirus SARS-CoV-2, they are strongly advised to take additional precautions to protect themselves (see Recommendations for vulnerable groups | RIVM.nl) and to get the booster vaccination or repeat booster against COVID-19.

All the weekly COVID-19 figures are presented in a table and in graphs on the RIVM website and in the weekly epidemiological update. A great deal of information can also be found on the Coronavirus Dashboard.

2 March 2022 | 9:15

Booster vaccination offers effective protection against hospital and ICU admission due to COVID-19

From 1 December 2021 to 22 February 2022, vaccine effectiveness for the COVID-19 booster vaccination was 94% against hospital admission and 98% against ICU admission.

Read the news: Booster vaccination offers effective protection against hospital and ICU admission due to COVID-19

1 March 2022 | 16:00 

Vaccination figures 21 to 27 February 2021

Number of vaccinations in the basic series

By Sunday 27 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. About 13.5 million of those were first vaccinations, and nearly 11.5 million were second vaccinations.  More than 133,000 third vaccinations were administered to people with severely impaired immunity. 

Read more in the Weekly update on COVID-19 vaccination figures. 

1 March 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2:  22 February to 1 March 2022

Last week, there were 26% fewer new hospital admissions and 15% fewer new ICU admissions of patients with SARS-CoV-2 compared to the week before. The number of newly reported positive COVID-19 tests decreased by 21% last week compared to the week before that. The reproduction number is below 1.

See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.  Much of the data used to keep track of the SARS-CoV-2 figures is available to the public. These open data files are published every day at 15:15.

22 February 2022 | 16:00

Vaccination figures 14 to 20 February 2021

Number of vaccinations in the basic series

By Sunday 20 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  More than 133,000 third vaccinations were administered to people with severely impaired immunity. 

Read more in the Weekly update on COVID-19 vaccination figures. 

22 February 2022 | 16:10 PM

Weekly update on the coronavirus SARS-CoV-2:  15 February to 22 February 2022

Read the news: Decrease in SARS-CoV-2 hospital admissions, fewer people tested 

1

5 February 2022 | 17:20

Booster vaccination prevents many hospital and ICU admissions

In the period from 26 January to 8 February 2022, the COVID-19 vaccines were 92% effective in preventing hospital admission after the booster, and 55% effective after the basic vaccinations. During this period, the vast majority of hospital admissions were caused by the Omicron variant of the coronavirus SARS-CoV-2. 

Read the news: Booster vaccination prevents many hospital and ICU admissions

15 February 2022 | 17:00

Vaccination figures 7 to 13 February 2021

Number of vaccinations in the basic series

By Sunday 13 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  About 133,000 third vaccinations have been administered to people with severely impaired immunity.

Read more in the Weekly update on COVID-19 vaccination figures. 

15 February 2022 | 16:50 PM

Weekly update on the coronavirus SARS-CoV-2:  8 February to 15 February 2022

Read the news: Omicron subvariant BA.2 becomes dominant, decrease in hospital admissions

8 February 2022 | 19:45 PM

Weekly update on the coronavirus SARS-CoV-2:  1 February to 8 February 2022

Read the news: Increase in COVID-19 hospital admissions, positive tests reaching high plateau

8 February 2022 | 16:00

Vaccination figures: 31 January 2022 to 6 February 2022

Number of vaccinations in the basic series

By Sunday 6 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  About 133,000 third vaccinations have been administered to people with severely impaired immunity. 

Read more in the Weekly update on COVID-19 vaccination figures. 

8 February 2022 | 14:00

Slight delay in weekly update on reported positive tests

The weekly update on positive tests and hospital admissions that RIVM normally posts on Tuesday around 15:00 hrs, and the accompanying open data, will be published later today. 

The number of reported positive COVID-19 tests rose dramatically over the past few weeks. Due to the high volume of positive test results, the Municipal Public Health Services (GGDs) has experienced delays in transmitting these figures to RIVM since 18 January 2022. As a result, the actual number of reported positive tests was higher than the numbers reported daily by RIVM. The reported positive tests from the GGD test lanes were first entered into a GGD system. From there, the reported positive test results were transferred to a second GGD system, where information from source and contact tracing was entered by hand. As of today, reported figures on positive tests will be sent directly from the GGD test lanes to RIVM; this includes the new reported positive tests and the previous positive tests that were not yet reported to RIVM. As a result of this catch-up action, RIVM will be reporting a particularly high number of positive tests today. Today’s weekly news item on COVID-19 figures will be delayed slightly, and is expected to be published between 16:00 and 16:30 hrs.

1 February 2022 | 19:00

Booster vaccination still very effective

From 1 December 2021 to 25 January 2022, vaccine effectiveness for the COVID-19 booster vaccination was 97% against hospital admission and 98% against ICU admission.

A booster vaccination provides more protection against hospital admission than only completing the basic series of COVID-19 vaccinations: 97% compared to 83%. This means that the risk of hospital admission after a booster vaccination is 33 times lower compared to no COVID-19 vaccinations and 5 times lower compared to a completed basic series without a booster. 

Read more about Booster vaccination still very effective

1 February 2022 | 16:00

Vaccination figures: 24 to 30 January 2022 

Number of vaccinations in the basic series

By Sunday 30 January 2022, it is estimated that more than 24.8 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  Nearly 133,000 third vaccinations have been administered to people with severely impaired immunity.  

Read more in the Weekly update on COVID-19 vaccination figures. 

1 February 2022 | 4:00 PM

Weekly update on the coronavirus SARS-CoV-2:  25 January to 1 February 2022

Read the news: Over half a million positive COVID-19 tests, more hospital admissions

28 January 2022 | 17:45

Update on backlog in positive COVID-19 tests

The backlog in the daily number of reported positive COVID-19 tests is currently about 72,000. This is due to the current high numbers of positive tests. All positive test results are entered into a system by the Municipal Public Health Services (GGDs). From that GGD system, the reported positive test results are then transferred to a second GGD system, where information from source and contact tracing is entered by hand. Due to the high volume of reported positive tests, entering this information takes a lot of work. Many aspects of this process have already been automated by the GGD recently, but the technical solution is not yet working optimally. As a result, there is a delay in sending the data from the GGD to RIVMNational Institute for Public Health and the Environment.

They are working to resolve the delay. It is expected to be resolved next week.

---

25 January 2022 | 16:45

Vaccination figures: 17 to 23 January 2022 

As of this week, the COVID-19 updates also include the number of vaccinations in the basic series and the number of booster vaccinations. In addition to vaccination coverage for the basic series, this update now also includes booster vaccination coverage by age group. 

Read more in the Weekly update on COVID-19 vaccination figures. 

---

25 January 2022 | 4:00 PM

Weekly update on the coronavirus SARS-CoV-2:  18 January to 25 January 2022

The number of reported positive COVID-19 tests increased by 51% last week compared to the week before that, rising to 366,120. Since 18 January 2022, an estimated 60,000 positive COVID-19 tests have not yet been reported to RIVMNational Institute for Public Health and the Environment as a result of the huge volume of positive test results at the Municipal Public Health Services (GGDs).* Based on the positive tests reported to RIVM in the past week, the biggest increase in reported positive tests  per 100,000 inhabitants was seen among children and adolescents in the primary school (+161%) and secondary school (+112%) age groups. There was also a clear increase in the number of positive COVID-19 tests among people in their thirties (+42%) and forties (+42%). The number of positive COVID-19 tests decreased in the age group of 18-24 years (-13%) (see Figure 1).The other age groups showed relatively minor differences from one week to the next. The number of people who were tested by the GGD increased by 37 in the past calendar week, compared to the week before that. After a period in which figures decreased, hospital admissions rose again in the past week. 855* new hospital admissions were reported last week, an increase of +15% compared to the week before that. This seems to mark a trend shift, with hospital admissions moving into an upward trend again. 65 new patients were admitted to ICU last week, a decrease of 34% compared to the week before that. The reproduction number based on the number of positive COVID-19 tests reported to RIVM* is still well below 1. 

* There is currently a backlog in the daily number of positive COVID-19 tests reported by RIVMNational Institute for Public Health and the Environment, compared to the actual figures reported by the Municipal Public Health Services (GGD). Numbers are currently so high that it is causing delays in sending the figures from the GGD system to RIVM. These figures do not include about 60,000 positive tests that were reported between 18 and 25 January 2022. A technical solution is being developed to catch up and eliminate this backlog, but it will take some time. The reproduction number based on reported infections may temporarily be too low due to the backlog, which will be corrected when the delayed reports have been incorporated.

** The NICE Foundation and the hospitals cannot yet distinguish between the number of patients who were admitted due to COVID-19 and the number of patients admitted to hospital who tested positive for SARS-CoV-2, but were admitted for another reason. They are working on a solution for that.

	Last week1	Two weeks ago2
Reports of people tested for SARS-CoV-2 who had a positive test result
Newly reported COVID-19 infections*	366,120 (2,034 per 100,000 inhabitants)	242,961 (1,380 per 100,000 inhabitants)
New hospital admissions (Source NICE)3	855	741
Of which new ICU admissions (Source: NICE)3	65	99
Deaths4	61	63
SARS-CoV-2 tests by the GGD per calendar week5,6	week 3	week 2
Total number of tests of which results are known Number of positive tests Percentage of positive tests**	949,034 431,549 45.4%	695,512 256,115 36.8%
Number of tests intended to confirm a positive self-test*** Number of positive tests after a positive self-test Percentage of positive tests after a positive self-test	241.779 218,286 90.3%	137.306 120.778 88.0%
Number of tests not intended to confirm a positive self-test Number of positive tests not after a positive self-test Percentage of positive tests not after a positive self-test	566,223 152,932 27.0%	451,249 98.780 21.9%
Number of tests for which it is unknown whether it was a confirmation test7 Number of positive tests for which it is unknown whether it was a confirmation test Percentage of positive tests for which it is unknown whether it was a confirmation test	141,932 60,331 42.5%	106,957 36,557 34.1%
	Latest calculation	One week before
Reproduction numbers8	On 10 January	On 3 January
Based on reported infections	1,19 (1,18 – 1,20)	1,16 (1,14 – 1,17)
	On 8 January****	On 1 January
Based on hospital admissions (Source: NICE)	0,99 (0,80 – 1,19)	0,95 (0,77 – 1,14)
Based on ICU admissions (Source: NICE)	0,85 (0,38 – 1,44)	0,92 (0,50 – 1,44)

---

25 January 2022 | 11:15 AM

Shorter serial interval for Omicron variant

The Omicron variant of the coronavirus SARS-CoV-2 spreads faster than the Delta variant. Researchers from RIVM conclude in a preprint article that this faster spread can be attributed at least partly to the fact that the Omicron variant appears to have a shorter serial interval. This is the time between the first day of illness for the source contact and the first day of illness for the person they infect. The researchers reached this conclusion by looking at infections within households. On a PCR test, the Omicron variant shows S-gene target failure (SGTF, also known as ‘S-dropout’) while the Delta variant does not. Researchers looked at the serial interval of households where S-dropout did or did not occur. The serial interval was 3.4 days in households that showed S-dropout on the PCR tests, and 3.9 days in households without S-dropout. That means that the serial interval is a half-day shorter for the Omicron variant compared to the Delta variant.

More information: Shorter serial intervals in SARS-CoV-2 cases with Omicron variant compared to Delta variant in the Netherlands, 13 - 19 December 2021 | medRxiv

---

20 January 2022 | 17:00 hrs

Backlog in figures for reported number of COVID-19 cases

There is currently a significant backlog in the daily number of positive COVID-19 tests reported by RIVM, compared to the actual figures reported by the Municipal Health Services (GGD). Numbers are currently so high that it is causing delays in transferring the figures from the GGD system to RIVM. The figures therefore do not yet include about 27,000 positive tests that were reported over the past three days. A technical solution is being developed to catch up and eliminate this backlog, but it will take some time. Therefore, the weekly RIVM update is currently the best way to monitor the course of the epidemic.

---

19 January 2022 | 4:00 PM

Booster vaccination very effective in preventing severe COVID-19

After a booster vaccination, the chance that a person infected with the coronavirus SARS-CoV-2 would be admitted to hospital was 33 times lower than for an unvaccinated person, and 5 times lower than for a person who had completed the basic series without a booster. The chance of ICU admission was 50 times lower after a booster compared to someone who is unvaccinated, and 4 times lower than for someone who had completed the basic series without a booster.* 

Effectiveness of booster vaccination in preventing hospital and ICU admission 

The booster vaccination campaign in the Netherlands started on 18 November 2021. For the first time, RIVM can now provide an update on the effectiveness of booster vaccination in preventing hospital and ICU admission. From 19 November 2021 to 13 January 2022, vaccine effectiveness for people who had received a booster vaccination was 97% against hospital admission and 98% against ICU admission. 

Read more about Booster vaccination very effective in preventing severe COVID-19

---

18 January 2022 | 4:00 PM

Vaccination figures: 10 to 16 January 2022 

By Sunday 16 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  

Read more about COVID-19 vaccination figures. 

---

18 January 2022 | 3:50 PM

Weekly update on the coronavirus SARS-CoV-2:  11 January to 18 January 2022

Read the news: Nearly a quarter-million positive COVID-19 tests last week

	Last week1	Two weeks ago2
Reports of people tested for SARS-CoV-2 who had a positive test result
Newly reported COVID-19 infections*	242,961 (1,380 per 100,000 inhabitants)	201,536 (1,147per 100,000 inhabitants)
New hospital admissions (Source NICE)3	647	940
Of which new ICU admissions (Source: NICE)3	94	146
Deaths4	63	116
SARS-CoV-2 tests by the GGD per calendar week5,6	week 2	week 1
Total number of tests of which results are known Number of positive tests Percentage of positive tests**	695,378 256,035 36.8%	589,657 201,388 34.2%
Number of tests intended to confirm a positive self-test*** Number of positive tests after a positive self-test Percentage of positive tests after a positive self-test	137,264 120,740 88.0%	102,171 90,240 88.3%
Number of tests not intended to confirm a positive self-test Number of positive tests not after a positive self-test Percentage of positive tests not after a positive self-test	451,160 98,739 21.9%	390,425 80,791 20.7%
Number of tests for which it is unknown whether it was a confirmation test7 Number of positive tests for which it is unknown whether it was a confirmation test Percentage of positive tests for which it is unknown whether it was a confirmation test	106,954 36,556 34.2%	97,061 30,357 31.2%
	Latest calculation	One week before
Reproduction numbers8	On 3 January	On 27 December
Based on reported infections	1,16 (1,14 – 1,17)	1,26 (1,24 – 1,28)
	On 1 January****	On 25 December
Based on hospital admissions (Source: NICE)	0,95 (0,77 – 1,14)	0,95 (0,78 – 1,12)
Based on ICU admissions (Source: NICE)	0,92 (0,50 – 1,44)	0,92 (0,53 – 1,38)

---

15 January 2022 | 09:00 AM

Advisory report of 138th OMT

On 12 January 2022, the Outbreak Management Team (OMT) convened to consult on the COVID-19 epidemic. Among other topics, the OMT discussed the following during this meeting:

• the latest epidemiologcal data on the coronavirus SARS-CoV-2;
• the expected course of the epidemic;
• the projected consequences of any relaxations in measures taken to prevent the spread of the virus;
• the use of face masks that cover the mouth and nose in public spaces;
• a change in the quarantine rules, allowing workers in crucial & vital professions to leave quarantine for work (after a negative self-test).

Read more in the advisory report of the 138th OMT  (in Dutch).

---

11 January 2022 | 4:15 PM

Vaccination figures: 3 to 9 January 2022 

By Sunday 9 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  

Read more about COVID-19 vaccination figures. 

11 January 2022 | 3:50 PM

Weekly update on the coronavirus SARS-CoV-2:  4 January to 11 January 2022

Read the news: 200 thousand people tested positive in one week

10 January 2022  | 21:19 PM

OMT advisory report, 7 January 2022

On 7 January 2022, the Outbreak Management Team (OMT) convened to consult on the COVID-19 outbreak. The OMT studied the latest epidemiological data on the coronavirus SARS-CoV-2 and issued an advisory report on the use of face masks that cover the mouth and nose. 

Read more in the advisory report of the 137th OMT (in Dutch). More information on the OMT can be found on the RIVM page about the Outbreak Management Team.

4 January 2022 | 4:15 PM

Weekly update on the coronavirus SARS-CoV-2:  28 December 2021 to 4 January 2022

Read the news: Omicron causes 35% increase in positive COVID-19 tests, despite lockdown

4 January 2022| 4:00 PM

Vaccination figures: 27 December 2021 - 2 January 2022

By Sunday 2 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and nearly 11.4 million were second vaccinations.  

Read more about COVID-19 vaccination figures.